Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination

Archive ouverte

Barateau, Véronique | Peyrot, Loïc | Saade, Carla | Pozzetto, Bruno | Brengel-Pesce, Karen | Elsensohn, Mad-Hélénie | Allatif, Omran | Guibert, Nicolas | Compagnon, Christelle | Mariano, Natacha | Chaix, Julie | Djebali, Sophia | Fassier, Jean-Baptiste | Lina, Bruno | Lefsihane, Katia | Espi, Maxime | Thaunat, Olivier | Marvel, Jacqueline | Rosa-Calatrava, Manuel | Pizzorno, Andres | Maucort-Boulch, Delphine | Henaff, Laetitia | Saadatian-Elahi, Mitra | Vanhems, Philippe | Paul, Stéphane | Walzer, Thierry | Trouillet-Assant, Sophie | Defrance, Thierry

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

The diversity of vaccination modalities and infection history are both variables that have an impact on the immune memory of individuals vaccinated against SARS-CoV-2. To gain more accurate knowledge of how these parameters imprint on immune memory, we conducted a long-term follow-up of SARS-CoV-2 spike protein-specific immune memory in unvaccinated and vaccinated COVID-19 convalescent individuals as well as in infection-naïve vaccinated individuals. Here, we report that individuals from the convalescent vaccinated (hybrid immunity) group have the highest concentrations of spike protein-specific antibodies at 6 months after vaccination. As compared with infection-naïve vaccinated individuals, they also display increased frequencies of an atypical mucosa-targeted memory B cell subset. These individuals also exhibited enhanced TH1 polarization of their SARS-CoV-2 spike protein-specific follicular T helper cell pool. Together, our data suggest that prior SARS-CoV-2 infection increases the titers of SARS-CoV-2 spike protein-specific antibody responses elicited by subsequent vaccination and induces modifications in the composition of the spike protein-specific memory B cell pool that are compatible with enhanced functional protection at mucosal sites.

Suggestions

Du même auteur

Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination

Archive ouverte | Pozzetto, Bruno | CCSD

Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine1,2, European health authorities recommended that patients under the age of 55?years who received one dose of ChAdOx1-S-nCoV-19 receive a second dose o...

BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals

Archive ouverte | Saade, Carla | CCSD

International audience. Immune memory is influenced by the frequency and type of antigenic challenges. Here, we performed a cross-sectional comparison of immune parameters following a BA.breakthrough infection in in...

Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles

Archive ouverte | Mouton, William | CCSD

International audience. Abstract Objectives In the post‐SARS‐CoV‐2 pandemic era, “breakthrough infections” are still documented, due to variants of concerns (VoCs) emergence and waning humoral immunity. Despite wide...

Chargement des enrichissements...